FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in Belgium

Biotech startups in Belgium

Updated 16 Nov 2026

Reset
Biotech startups in Belgium
One-time CSV
  • 66 funded companies, 42 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~belgium.csv66 rows × 18 columns
CompanyCityLast roundAmountDate
Amyl TherapeuticsLiègeSeries A$9.6M2026-09-01
EsoBiotecMont-saint-guibertSeries A$2.2M2023-12-12
Augustine TherapeuticsLeuvenSeries A$83.9M2025-03-24
BioxodesMarche-en-famenneSeries A$6.4M2025-12-10
AxithraGenkSeed$10.7M2023-09-05
CryoTherapeuticsAnsSeries B$10.8M2024-04-02
MOLECUBESGhentSeed$2.1M2016-01-07

7 rows of the CSV in 5 of its 18 columns.

66
Startups
$853.7M
Total raised
7
Funded in the last 12 months
$164.6M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

7 of 66
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Amyl Therapeutics Amyl Therapeutics is a preclinical biotechnology company developing immunotherapy for neurodegenerative diseases. Biotech Liège Series A $9.6M 2026-09-01 $44.0M Meusinvest (Noshaq), Sambrinvest, Mérieux Equity Partners +1 1 to 10 2020
Bioxodes Bioxodes develops high value products derived from natural sources. Biotech Marche-en-famenne Series A $6.4M 2025-12-10 $25.6M European Commission 11 to 50 2013
Augustine Therapeutics Augustine Therapeutics discovers and develops medicines for neuromuscular and neurodegenerative diseases. Biotech Leuven Series A $83.9M 2025-03-24 $106.8M PMV, V-Bio Ventures, VIB 11 to 50 2019
EsoBiotec EsoBiotec is a Belgian biotechnology company that discovers novel cancer therapies. Biotech Mont-saint-guibert Series A $2.2M 2023-12-12 Thuja Capital, Sambrinvest, S.R.I.W. +2 11 to 50 2020
ArtiQ ArtiQ develops AI-based software that helps doctors interpret lung function tests and diagnose lung diseases. Artificial intelligence Leuven Seed $1.1M 2019-07-15 KBC, Gemma Frisius Fund 11 to 50 2019
ONTOFORCE ONTOFORCE is a Belgian semantic technology company that provides solutions for improving information management. Biotech Ghent Series A $5.3M 2018-01-25 PMV, Limburgse Reconversie Maatschappij, Korys 11 to 50 2011
CMOSIS nv CMOSIS nv designs and supplies standard and custom CMOS image sensors for professional, scientific, and industrial uses. Biotech Antwerp Series C $4.2M 2009-08-10 Capital-E, Vinnof 51 to 100 2007

Table 1. Biotech startups in Belgium: the 7 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 66.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Amyl Therapeutics Amyl Therapeutics is a preclinical biotechnology company developing immunotherapy for neurodegenerative diseases. Biotech Liège Series A $9.6M 2026-09-01 $44.0M Meusinvest (Noshaq), Sambrinvest, Mérieux Equity Partners +1 1 to 10 2020
2 Bioxodes Bioxodes develops high value products derived from natural sources. Biotech Marche-en-famenne Series A $6.4M 2025-12-10 $25.6M European Commission 11 to 50 2013

Table 2. Biotech startups in Belgium: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Meusinvest (Noshaq) Venture capital firm Liège, Belgium 3 5% 1 Amyl Therapeutics
2 Sambrinvest Venture capital firm Gosselies, Belgium 2 3% 1 Amyl Therapeutics
3 PMV Government investment office Brussels, Belgium 2 3%
4 Mérieux Equity Partners Private equity firm Lyon, France 1 2% 1 Amyl Therapeutics
5 Smedvig Family office Stavanger, Norway 1 2% 1 Amyl Therapeutics
6 S.R.I.W. Government investment office Liège, Belgium 1 2%
7 Thuja Capital Startup accelerator Utrecht, The Netherlands 1 2%
8 UCB Ventures Corporate venture arm Brussels, Belgium 1 2%
9 Invivo Capital Partners Venture capital firm Barcelona, Spain 1 2%
10 VIB Venture capital firm Ghent, Belgium 1 2%
11 V-Bio Ventures Venture capital firm Ghent, Belgium 1 2%
12 European Commission Government investment office Brussels, Belgium 1 2% 1 Bioxodes
13 Kurma Partners Venture capital firm Paris, France 1 2%
14 imec.xpand Venture capital firm Leuven, Belgium 1 2%
15 Korys Family office Halle, Belgium 1 2%

Table 3. Biotech startups in Belgium: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 51 77% $777.4M
Software 7 11% $13.8M
Artificial intelligence 3 5% $11.7M
Fintech 1 2%
Cybersecurity 1 2%
Education 1 2%
Commerce 1 2%
Hardware 1 2% $2.1M

Table 4. Biotech startups in Belgium by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 1 2% $100K
Seed 20 30% $4.5M
Series A 25 38% $9.2M
Series B 13 20% $13.6M
Series C 4 6% $13.6M
Series D+ 3 5% $43.3M

Table 5. Biotech startups in Belgium by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Ghent 9 14%
Liège 6 9%
Leuven 6 9%
Brussels 5 8%
Gosselies 5 8%
Louvain-la-neuve 4 6%
Antwerp 3 5%
Zwijnaarde 3 5%
Mont-saint-guibert 2 3%
Genk 2 3%
Hasselt 2 3%
Heverlee 1 2%

Table 6. Biotech startups in Belgium by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 2 29% $14.6M
September 2026 2 29% $11.7M
August 2026 1 14% $6.8M
April 2026 1 14% $125.0M
December 2025 1 14% $6.4M

Table 7. Biotech startups in Belgium: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 6 9% $158.1M
2025 9 14% $209.9M
2024 5 8% $172.8M
2023 6 9% $148.2M
2022 4 6% $171.3M
2021 7 11% $88.6M

Table 8. Biotech startups in Belgium by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 6 9%
2020 to 2022 14 21%
2015 to 2019 25 38%
2010 to 2014 11 17%
Before 2010 10 15%

Table 9. Biotech startups in Belgium by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 19 29%
11 to 50 39 59%
51 to 100 3 5%
101 to 250 3 5%
251 to 500 1 2%
10,001 or more 1 2%

Table 10. Biotech startups in Belgium by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Belgium are on the list?
66, in the file dated 16 November 2026. 7 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 66 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in Belgium: 66 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in Belgium by funding stage

Other sectors in Belgium

Biotech startups elsewhere

Cite: FundingWatcher, 66 funded biotech companies in Belgium, 16 November 2026. https://fundingwatcher.com/startups/biotech/belgium/